Shares of Foundation Medicine, Inc. (NASDAQ:FMI) opened at $67.5, and ended -4.92% lower at $63.8. Nearly 0.34 million shares were traded by the close, higher than its average daily volume of 0.22 million shares.Foundation Medicine, Inc. (FMI) Analyst Opinion
Foundation Medicine, Inc. has a consensus hold rating from 5 Wall Street analysts, and the number of shares currently sold short amount to at least 15.98% of shares outstanding. The stock spiked 30.34% last month and is up 260.45 this year. Wall Street is only getting more bullish on the stock, with 1 of analysts who cover FMI having a buy-equivalent rating. Analysts have placed a $45.67 price target on Foundation Medicine, Inc., suggesting a -28.42% decline from recent close. It’s currently trading about -9.82% below its 52-week high.
Foundation Medicine, Inc. (FMI) surprised the stock market in its last reported earnings when it earned -$0.9 a piece versus the consensus-estimated -$1.1. Its revenue totaled $37.99 million up 8.54% from the previous quarter.Foundation Medicine, Inc. (NASDAQ:FMI) Intraday View
This stock (FMI) is ahead of its 52-week low with 273.1%. Its last month’s stock price volatility remained 7.96% which for the week stands at 6.5%. The share price has moved forward from its 20 days moving average, trading at a distance of 18.97% and stays 32.45% away from its 50 days moving average. Over the last five days, shares have managed 2.49% gains and now is up 61.74% since hitting its 200-day moving average of $42.37. Foundation Medicine, Inc. (FMI) has made its way to a 12-month gain of 211.98%.
Turning to GDS Holdings Limited (NASDAQ:GDS), its shares were trading at $19.55 a gain of $0.91, on the trading floor. The stock, after opening at $18.65, touched a high of $19.61 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2. GDS Holdings Limited has 1 buy ratings, 1 holds and 0 sells even after the stock tumbled -6.01% from its high of $20.80 to a $2.25 billion market value through last close.
The company’s consensus rating on Reuter’s scale improved from 1.8 to 2 during a month. Analysts set a 12-month price target of $20.81 a share. The target implies a 6.45% spike from where the shares are currently trading. Also, the current price highlights a discount of 18.67% to analysts’ high consensus price target.GDS Holdings Limited (NASDAQ:GDS) Intraday Trading
The counter witnessed a trading volume of 0.35 million shares versus an average volume of 0.49 million shares during last trading session. Its last month’s stock price volatility remained 6.77% which for the week approaches 5.17%. The lowest price the stock reached in the last trading day was $18.65 and compares with the $6.90 52-week low. The stock recovered 183.33% since its low point and has performed 127.33% year-to-date.